Achieve Life Sciences, Inc.
ACHV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,827 | -$29,815 | -$42,350 | -$33,152 |
| Dep. & Amort. | $229 | $228 | $236 | $250 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,325 | $3,439 | $3,270 | $2,187 |
| Change in WC | $2,412 | -$778 | $79 | $1,234 |
| Other Non-Cash | $2,091 | $2,447 | $1,196 | $41 |
| Operating Cash Flow | -$29,770 | -$24,479 | -$37,569 | -$29,440 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$21 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$47,887 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $26,307 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$21,580 | -$21 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$8,295 | $0 | $0 | $14,929 |
| Stock Issued | $56,076 | $15,301 | $19,212 | $21,343 |
| Stock Repurch. | $0 | -$30 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $746 | $7 | $103 | $338 |
| Financing Cash Flow | $48,527 | $15,278 | $19,315 | $36,610 |
| Forex Effect | $0 | -$3 | $3 | -$1 |
| Net Chg. in Cash | -$2,823 | -$9,225 | -$18,251 | $7,169 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,596 | $24,771 | $43,072 | $35,903 |
| End Cash | $12,773 | $15,546 | $24,821 | $43,072 |
| Free Cash Flow | -$29,770 | -$24,500 | -$37,569 | -$29,440 |